Zymeworks Inc. (NYSE:ZYME) Q3 2024 Earnings Call Transcript
Operator: Hello. Thank you for standing by. This is the conference operator. Welcome to Zymeworks First Quarter 2024 Results Conference Call and Webcast.
Zymeworks Bc Inc. (ZYME)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Samsara BioCapital Srini Akkaraju And Michael Dybbs | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $14.28 | 3,600 | Officer | 7,119 | 2022-01-07 | Filing | |
| $14.27 | 1,400 | Officer | 3,519 | 2022-01-07 | Filing | |
| $33.39 | 80 | Officer, Director | 59,861 | 2020-04-03 | Filing | |
| $33.39 | 495 | Officer, Director | 59,781 | 2020-04-03 | Filing | |
| $46.50 | 7,500 | Director | 7,500 | 2020-01-27 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.10 | 2,475 | Officer | 14,449 | 2022-11-10 | Filing | |
| $6.88 | 2,979 | Officer | 13,276 | 2022-03-10 | Filing | |
| $36.00 | 41,191 | Officer, Director | 260,325 | 2021-07-16 | Filing | |
| $36.00 | 3,800 | Officer, Director | 260,325 | 2021-07-15 | Filing | |
| $36.12 | 12,669 | Officer, Director | 260,325 | 2021-07-12 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% |
News See All
Zymeworks Inc. (NYSE:ZYME) Q2 2024 Earnings Call Transcript
Operator: Thank you for standing by. This is the conference operator. Welcome to Zymeworks Second Quarter 2024 Results Conference Call and Webcast.
Zymeworks Inc. (NYSE:ZYME) Q1 2024 Earnings Call Transcript
Zymeworks Inc. misses on earnings expectations. Reported EPS is $-0.41513 EPS, expectations were $-0.31. Zymeworks Inc.
12 Most Undervalued Biotech Stocks To Buy According To Hedge Funds
In this article, we discuss 12 most undervalued biotech stocks to buy according to hedge funds.
Zymeworks Inc. (NYSE:ZYME) Q4 2023 Earnings Call Transcript
Zymeworks Inc. beats earnings expectations. Reported EPS is $-0.2, expectations were $-0.39. Zymeworks Inc.
18 High Growth Low PE Stocks
When value stocks came back with a vengeance in 2022, value investors cheered what they thought was the beginning of a long bull run of value stocks.
5 Best Healthcare Stocks For the Long-Term
In this piece, we will take a look at the five best healthcare stocks for the long term.
Zymeworks Inc. (NYSE:ZYME) Q3 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Zymeworks Third Quarter 2023 Results Conference Call. At this time, all participants are in a listen-only mode.
12 Cheap Biotech Stocks Smart Investors Are Piling Into
In this piece, we will take a look at 12 cheap biotechnology stocks that smart investors are piling into.
13 NASDAQ Stocks with Lowest PE Ratios That May Not Be Value Traps
In this piece, we will take a look at the 13 NASDAQ stocks with lowest PE ratios. If you want to skip our primer on one of the best performing U.S.
Billionaire Hedge Funds
